13F HOLDINGS REPORT
MPM ASSET MANAGEMENT LLC
Quarter ended Q2 2023 · Filed May 12, 2023 · Accession 0000950123-23-004667
Total Value
$240.0M
Positions
9
Other Managers
0
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Entrada Therapeutics, Inc. | TRDA | 4,425,784 | $64.2M | 26.74% |
| 2 | Dyne Therapeutics, Inc. | DYN | 4,951,303 | $57.0M | 23.77% |
| 3 | Amryt Pharma plc | 03217L106 | 2,668,843 | $38.9M | 16.21% |
| 4 | iTeos Therapeutics, Inc. | 46565G104 | 2,738,785 | $37.3M | 15.53% |
| 5 | Repare Therapeutics, Inc. | 760273102 | 2,242,636 | $22.1M | 9.20% |
| 6 | Werewolf Therapeutics, Inc. | HOWL | 4,284,172 | $11.1M | 4.64% |
| 7 | TCR2 Therapeutics, Inc. | 87808K106 | 4,050,865 | $6.1M | 2.53% |
| 8 | Harpoon Therapeutics, Inc. | 41358P106 | 3,131,388 | $2.3M | 0.97% |
| 9 | Oncorus, Inc. | 68236R103 | 2,849,464 | $980,216 | 0.41% |